NATR (STOCKS)
Nature's Sunshine Products Inc.
$26.500000
+0.360000 (+1.38%)
Prev close: $26.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Kenneth G. Romanzi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $463.28M
- Employees
- 819
- P/E (TTM)
- 32.66
- P/B (TTM)
- 2.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $474.54M |
| Benefits Costs and Expenses | $448.77M |
| Cost Of Revenue | $131.53M |
| Costs And Expenses | $448.77M |
| Gross Profit | $343.01M |
| Operating Expenses | $319.04M |
| Selling, General, and Administrative Expenses | $173.68M |
| Other Operating Expenses | $143.66M |
| Operating Income/Loss | $23.97M |
| Income/Loss From Continuing Operations After Tax | $15.21M |
| Income/Loss From Continuing Operations Before Tax | $25.77M |
| Income Tax Expense/Benefit | $10.57M |
| Income Tax Expense/Benefit, Deferred | -$3.79M |
| Net Income/Loss | $15.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $113.00K |
| Net Income/Loss Attributable To Parent | $15.09M |
| Net Income/Loss Available To Common Stockholders, Basic | $15.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.83 |
| Diluted Earnings Per Share | $0.81 |
| Basic Average Shares | 18,129,000 |
| Diluted Average Shares | 18,537,000 |
| Assets | $264.81M |
| Current Assets | $186.08M |
| Inventory | $67.34M |
| Other Current Assets | $118.75M |
| Noncurrent Assets | $78.72M |
| Fixed Assets | $33.97M |
| Other Non-current Assets | $44.75M |
| Liabilities | $98.10M |
| Current Liabilities | $83.65M |
| Accounts Payable | $7.12M |
| Other Current Liabilities | $76.53M |
| Noncurrent Liabilities | $14.45M |
| Equity | $166.70M |
| Equity Attributable To Noncontrolling Interest | $6.20M |
| Equity Attributable To Parent | $160.50M |
| Liabilities And Equity | $264.81M |
| Net Cash Flow From Operating Activities | $37.61M |
| Net Cash Flow From Operating Activities, Continuing | $37.61M |
| Net Cash Flow From Investing Activities | -$6.34M |
| Net Cash Flow From Investing Activities, Continuing | -$6.34M |
| Net Cash Flow From Financing Activities | -$15.82M |
| Net Cash Flow From Financing Activities, Continuing | -$15.82M |
| Exchange Gains/Losses | $1.41M |
| Net Cash Flow | $16.85M |
| Net Cash Flow, Continuing | $15.45M |
| Comprehensive Income/Loss | $14.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $196.00K |
| Comprehensive Income/Loss Attributable To Parent | $14.28M |
| Other Comprehensive Income/Loss | -$726.00K |